The NF-κB pathway is highly associated with BC, as shown by its inhibition via parthenolide that inhibits TNBC progression, inducing apoptosis in mammary tumors, enhancing chemo-sensitivity in BC cells, and suppressing metastatic markers in TNBC [15,16,17,18]. Here, NFKB1 is linked to breast cancer.